We are live on ! Find out more
OS

Objectivity Squared Portfolio holdings

AUM $159M
1-Year Est. Return 22.15%
This Fund
S&P 500
This Quarter Est. Return
+1.97%
1 Year Est. Return
+22.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$159M
AUM Growth
-$20.1M
Cap. Flow
-$21.5M
Cap. Flow %
-13.56%
Top 10 Hldgs %
76.3%
Holding
58
New
1
Increased
18
Reduced
29
Closed
3

Top Buys

Rank Stock Value
1
EWC icon
iShares MSCI Canada ETF
EWC
+$497K
2
AIA icon
iShares Asia 50 ETF
AIA
+$368K
3
USAC icon
USA Compression Partners
USAC
+$125K
4
MPLX icon
MPLX
MPLX
+$107K
5
SPTI icon
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
+$91.2K

Top Sells

Rank Stock Value
1
XOCT icon
FT Vest US Equity Enhance & Moderate Buffer ETF October
XOCT
+$15.1M
2
XMAY
FT Vest U.S. Equity Enhance & Moderate Buffer ETF - May
XMAY
+$1.22M
3
IWD icon
iShares Russell 1000 Value ETF
IWD
+$1.22M
4
AKRE
Akre Focus ETF
AKRE
+$751K
5
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$732K

Sector Composition

Rank Sector Weight
1 Energy 10.44%
2 Technology 7.74%
3 Communication Services 6.07%
4 Industrials 2.68%
5 Consumer Discretionary 1.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AKRE
51
Akre Focus ETF
AKRE
$5.14B
$217K 0.14%
4,109
-12,923
-76% -$751K
BRK.B icon
52
Berkshire Hathaway Class B
BRK.B
$1.07T
$205K 0.13%
428
-10
-2% -$4.91K
LLY icon
53
Eli Lilly
LLY
$1.06T
$201K 0.13%
219
-30
-12% -$30.4K
GNW icon
54
Genworth Financial
GNW
$3.81B
$156K 0.1%
19,182
– –
DARE icon
55
Dare Bioscience
DARE
$19.2M
$19.9K 0.01%
10,915
– –
ANIK icon
56
Anika Therapeutics
ANIK
$199M
– –
-31,575
Closed -$303K
XOCT icon
57
FT Vest US Equity Enhance & Moderate Buffer ETF October
XOCT
$71.5M
– –
-400,009
Closed -$15.1M
XMAY
58
FT Vest U.S. Equity Enhance & Moderate Buffer ETF - May
XMAY
$18.9M
– –
-35,025
Closed -$1.22M
1 2
3

Similar funds

BDAM
Blue Door Asset Management Stamford, Connecticut $159M AUM 38.2% 1-Year Est. Return
OC
Oppenheimer & Close New York $159M AUM 60.56% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
JF
Jericho Financial Westerville, Ohio $159M AUM 27.21% 1-Year Est. Return
1L
10Elms LLP Tulsa, Oklahoma $159M AUM 13.16% 1-Year Est. Return
USWIA
UP Strategic Wealth Investment Advisors Pittsburgh, Pennsylvania $159M AUM 24.31% 1-Year Est. Return
EWA
Elevate Wealth Advisory Athens, Georgia $158M AUM 15.64% 1-Year Est. Return
RP
RIHO Partners Tucson, Arizona $159M AUM

Objectivity Squared's Q1 2026 Portfolio in Review

As of Q1 2026, Objectivity Squared held 58 positions worth $159M, down 11% from $179M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Objectivity Squared withdrew a net $21.5M in Q1 2026, closing 3 positions and reducing 29 holdings. Its most notable exit was FT Vest US Equity Enhance & Moderate Buffer ETF October, an estimated $15.1M position sold in full.

By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 7.8% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Objectivity Squared opened a new position in iShares MSCI Canada ETF worth $490K.

  • Objectivity Squared's largest Q1 2026 buy was iShares MSCI Canada ETF: 8,944 shares worth $490K.
  • Objectivity Squared added most to iShares Asia 50 ETF in Q1 2026, an estimated $368K increase.
  • Objectivity Squared's biggest Q1 2026 reduction was iShares Russell 1000 Value ETF, cutting an estimated $1.22M.
  • Objectivity Squared fully exited FT Vest US Equity Enhance & Moderate Buffer ETF October in Q1 2026, selling an estimated $15.1M.
  • Objectivity Squared's ten largest holdings make up 76% of its $159M portfolio in Q1 2026.
  • Objectivity Squared opened 1 new position and closed 3 in Q1 2026.
  • Objectivity Squared's portfolio value fell 11% quarter-over-quarter to $159M.

Based on Objectivity Squared's 13F filing for Q1 2026, filed 13 May 2026.